Literature DB >> 3510912

Nutritional parameters that alter hepatic drug metabolism, conjugation, and toxicity.

W R Bidlack, R C Brown, C Mohan.   

Abstract

A major concern of contemporary medicine is the adverse effects resulting from the use of prescribed and over-the-counter pharmacologic agents. In many cases more than one drug is taken at the same time, which increases the risk of overloading the detoxification mechanisms. If the individual has poor nutritional status, the system becomes even more inefficient. The liver contains the most important of these detoxification systems: the cytochrome P-450-dependent mixed function oxidase (MFO) and several conjugation enzymes, e.g., sulfotransferase, glucuronyl transferase, and glutathione transferase, which convert lipophilic compounds to more water-soluble products to enhance their excretion. The balance of these reactions determines the rate of metabolism and clearance of xenobiotic agents, and regulates in part the degree of intracellular damage. Nutritional factors, including proteins, carbohydrates, fats, vitamins, and minerals, affect the efficiency of these reactions. Changes in intracellular metabolism can alter not only the enzyme levels but also the availability of their cofactors, e.g., NADPH, UDPGA (uridine diphosphate glucuronic acid), PAPS (3'-phosphoadenosine-5'-phosphosulfate), and GSH. Diets restricted in calories, protein, or essential fatty acids, as well as those having low quality protein or high sugar content, can affect the component enzymes, cytochrome P-450 and the cytochrome P-450 reductase, and the MFO activity toward a variety of drugs. In addition, deficiencies of specific vitamins (riboflavin, ascorbic acid, and vitamins A and E) and minerals (iron, copper, zinc, and magnesium) affect the components and activities of the system in unique ways. Insight into the regulation of the hepatic detoxification mechanism can be gained by using nutrient variables to perturb the system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3510912

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  10 in total

1.  Influence of a very low calorie diet on the clearance of oxazepam and antipyrine in man.

Authors:  J Sonne; J Dragsted; S Loft; M Døssing; F Andreasen
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  Effects of dietary heated fats on rat liver enzyme activity.

Authors:  C Lamboni; E G Perkins
Journal:  Lipids       Date:  1996-09       Impact factor: 1.880

3.  Effect of a low-protein diet on doxorubicin pharmacokinetics in the rabbit.

Authors:  B J Cusack; S P Young; V L Loseke; M R Hurty; L Beals; R D Olson
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

4.  Effects of two plant secondary metabolites, cineole and gallic acid, on nightly feeding patterns of the common brushtail possum.

Authors:  Natasha L Wiggins; Clare McArthur; Stuart McLean; Rebecca Boyle
Journal:  J Chem Ecol       Date:  2003-06       Impact factor: 2.626

5.  Effect of the degree of hydrogenation of dietary fish oil on the trans fatty acid content and enzymatic activity of rat hepatic microsomes.

Authors:  N Morgado; A Galleguillos; J Sanhueza; A Garrido; S Nieto; A Valenzuela
Journal:  Lipids       Date:  1998-07       Impact factor: 1.880

6.  The influence of diet upon liver function tests and serum lipids in healthy male volunteers resident in a Phase I unit.

Authors:  L Purkins; E R Love; M D Eve; C L Wooldridge; C Cowan; T S Smart; P J Johnson; W G Rapeport
Journal:  Br J Clin Pharmacol       Date:  2004-02       Impact factor: 4.335

7.  Effect of birch (Betula pendula) bark and food protein level on root voles (Microtus oeconomus): II. detoxification capacity.

Authors:  A Harju
Journal:  J Chem Ecol       Date:  1996-04       Impact factor: 2.626

8.  Water Soluble Vitamin E Administration in Wistar Rats with Non-alcoholic Fatty Liver Disease.

Authors:  Irene P Tzanetakou; Ilias P Doulamis; Laskarina-Maria Korou; George Agrogiannis; Ioannis S Vlachos; Alkisti Pantopoulou; Dimitri P Mikhailidis; Efstratios Patsouris; Ioannis Vlachos; Despina N Perrea
Journal:  Open Cardiovasc Med J       Date:  2012-08-10

9.  Blood-Based Lipidomics Approach to Evaluate Biomarkers Associated With Response to Olanzapine, Risperidone, and Quetiapine Treatment in Schizophrenia Patients.

Authors:  Adriano Aquino; Guilherme L Alexandrino; Paul C Guest; Fabio Augusto; Alexandre F Gomes; Michael Murgu; Johann Steiner; Daniel Martins-de-Souza
Journal:  Front Psychiatry       Date:  2018-05-25       Impact factor: 4.157

10.  Membrane phospholipid augments cytochrome P4501a enzymatic activity by modulating structural conformation during detoxification of xenobiotics.

Authors:  Manik C Ghosh; Arun K Ray
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.